Family Medicine

In a study presented at ATS 2020, investigators test 3 different dosing regimens of tezepelumab in asthma patients with both high and low levels of IL-5 and IL-13.

A famed virologist weighs in on the country's earliest shortcomings—and how they can still be resolved today.

A one-time intramuscular dose of the investigative drug was linked to reduced medical attention and hospitalizations related to RSV.

A new study has great implications for equitable access to primary care for older adults during the pandemic.

In a pair of studies, 42% of patients and care partners reported having no current treatment.

Being outside is safer than being inside with a lot of people.

Pediatrics is leading the way in prescribing nature.

Impairment in reward-processing subcomponent categories is associated with tasks assessing option valuation, reward bias, and reinforcement learning.

A total of 115 of 200 examined eyes had some form of diabetic retinopathy in data presented at the ASRS 2020 virtual meeting.

In research presented at ASRS 2020, investigators found 56% of patients with PDR had a DME code, with a sensitivity of 85%.

In a study presented at ASRS 2020, investigators find an improvement in DRSS is not correlated with a change in best corrected visual acuity.

Using the 4 JAMA benchmarks, investigators do not find any online articles that are entirely accurate and accountable.

Steroids are often prescribed for diabetic macular edema following ineffectiveness of laser photocoagulation and anti-VEGF.

In data presented virtually during the ASRS 2020 meeting, investigators find X-82 is non inferior in visual acuity outcomes.

As of February, 121 unique therapies are involved in clinical trials for Alzheimer disease, with putative disease-modifying agents targeting disease onset or progression accounting for the largest number.

Kim Kjøller, MD, breaks down the findings from ECZTRA1, 2, and 3.

The approval are based on a pair of recent phase 3 trials showing the safety and efficacy of budesonide/glycopyrrolate/formoterol fumarate.

Kim Kjøller, MD, discusses how tralokinumab can be used for the treatment of atopic dermatitis.

Until more is known about long-term cardiac mechanisms behind MIS-C, providers could consider following Kawasaki disease guidelines for follow-up care

Patients in the DBT group were less likely to drop out early and had higher rates of symptomatic remission than a comparison CPT treatment group.

Although nature is beneficial, other social determinants of health might need to be addressed more imminently.

It has been notoriously difficult to measure sensitization to the alpha-Gal carbohydrate.

Canagliflozin is a known treatment for kidney disease, as well as heart failure in patients with type 2 diabetes and diabetic nephropathy.

The ongoing COVID-19 pandemic has forced several ophthalmologists to cancel appointments with patients who might be at a risk of developing sight-threatening illnesses.

An expert discusses nature counseling, how to prescribe it, and who might benefit from it.